Avidity Biosciences share price today

(RNA)

Avidity Biosciences share price is $31.64 & ₹2,692.41 as on 24 Dec 2024, 2.30 'hrs' IST

$31.64

▲

-0.18

(-0.57%)

Market is closed - opens 8 PM, 24 Dec 2024

View live Avidity Biosciences share price in Dollar and Rupees. Guide to invest in Avidity Biosciences from India. Also see the sentimental analysis on Indian investors investing in Avidity Biosciences. Get details on the Indian mutual funds that are investing in Avidity Biosciences. Get Analyst recommendations and forecasts along with all the Avidity Biosciences's financials.

Avidity Biosciences share price movements

Today's Low: $30.96
Today's High: $32.11
$31.64
2.15%
Downside
Day's Volatility :3.58%
Upside
1.46%
52 Weeks Low: $8.86
52 Weeks High: $56.00
$31.64
72.0%
Downside
52 Weeks Volatility :84.18%
Upside
43.5%

Avidity Biosciences Returns

Period	Avidity Biosciences Inc	Sector (Health Care)	Index (Russel 2000)
3 Months	-28.09%	-10.0%	0.0%
6 Months	-18.77%	-5.7%	0.0%
1 Year	237.67%	2.8%	0.0%
3 Years	25.66%	-0.4%	-21.1%

Avidity Biosciences Key Statistics

in dollars & INR

Previous Close	$31.82
Open	$31.32
Today's High	$32.11
Today's Low	$30.96
Market Capitalization	$3.8B
Today's Volume	$1.1M
52 Week High	$56.0
52 Week Low	$8.86
Revenue TTM	$10.1M
EBITDA	$-322.0M
Earnings Per Share (EPS)	$-2.88
Profit Margin	0.0%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-27.76%

How to invest in Avidity Biosciences from India?

It is very easy for Indian residents to invest directly in Avidity Biosciences from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Avidity Biosciences stock in both Indian Rupees (INR) and US Dollars (USD). Search for Avidity Biosciences or RNA on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Avidity Biosciences or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Avidity Biosciences shares which would translate to 0.027 fractional shares of Avidity Biosciences as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Avidity Biosciences, in just a few clicks!

Returns in Avidity Biosciences for Indian investors in Rupees

Investment Value

₹1,00,000

Avidity Biosciences investment value today

Current value as on today

₹3,39,995

Returns

₹2,39,995

(+240%)

Returns from Avidity Biosciences Stock

₹2,37,673 (+237.67%)

Dollar Returns

₹2,322 (+2.32%)

Indian investors sentiment towards Avidity Biosciences

-56%

Period: Sep 24, 2024 to Dec 23, 2024. Change in 30 Days versus previous period

Search volume for Avidity Biosciences on INDmoney from India has reduced in the last 30 days as on Dec 24, 2024. -56% less investors are searching Avidity Biosciences in the last 30 days versus the previous period.

Global Institutional Holdings in Avidity Biosciences

FMR Inc
14.12%
T. Rowe Price Associates, Inc.
8.91%
Vanguard Group Inc
7.73%
BlackRock Inc
7.23%
RTW INVESTMENTS, LLC
6.82%
Wellington Management Company LLP
5.89%

Analyst Recommendation on Avidity Biosciences

Buy

91%Buy

8%Hold

0%Sell

Based on 12 Wall street analysts offering stock ratings for Avidity Biosciences(by analysts ranked 0 to 5 stars)

Based on 12 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Avidity Biosciences

What analysts predicted

Upside of 115.78%

Current:

$31.64

Target:

$68.27

Insights on Avidity Biosciences

Price Movement
In the last 1 month, RNA stock has moved down by -26.8%
Increasing Revenue
Revenue is up for the last 2 quarters, 2.04M → 2.33M (in $), with an average increase of 12.5% per quarter
Decreasing Net Profit
Netprofit is down for the last 6 quarters, -47.02M → -80.39M (in $), with an average decrease of 11.4% per quarter
RNA vs VRTX (3 yr)
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 24.7% return, outperforming this stock by 1.2%

Avidity Biosciences Financials in INR & Dollars

	FY18	Y/Y Change
Revenue	$379.0K	↓ 97.1%
Net Income	$-11.9M	-
Net Profit Margin	-3.1K%	-

	FY19	Y/Y Change
Revenue	$2.3M	↑ 511.87%
Net Income	$-32.1M	↑ 169.16%
Net Profit Margin	-1.4K%	↑ 1763.69%

	FY20	Y/Y Change
Revenue	$6.8M	↑ 192.67%
Net Income	$-44.0M	↑ 36.93%
Net Profit Margin	-648.03%	↑ 737.09%

	FY21	Y/Y Change
Revenue	$9.3M	↑ 37.41%
Net Income	$-117.4M	↑ 166.86%
Net Profit Margin	-1.3K%	↓ 610.49%

	FY22	Y/Y Change
Revenue	$9.2M	↓ 1.09%
Net Income	$-169.1M	↑ 44.05%
Net Profit Margin	-1.8K%	↓ 574.49%

	FY23	Y/Y Change
Revenue	$9.6M	↑ 3.64%
Net Income	$-212.2M	↑ 25.52%
Net Profit Margin	-2.2K%	↓ 386.86%

	Q2 FY23	Q/Q Change
Revenue	$2.3M	↑ 3.72%
Net Income	$-47.0M	↓ 0.35%
Net Profit Margin	-2.0K%	↑ 82.95%

	Q3 FY23	Q/Q Change
Revenue	$2.8M	↑ 21.68%
Net Income	$-52.4M	↑ 11.34%
Net Profit Margin	-1.9K%	↑ 172.46%

	Q4 FY23	Q/Q Change
Revenue	$2.2M	↓ 22.18%
Net Income	$-60.4M	↑ 15.44%
Net Profit Margin	-2.8K%	↓ 898.2%

	Q1 FY24	Q/Q Change
Revenue	$3.5M	↑ 61.56%
Net Income	$-68.9M	↑ 13.92%
Net Profit Margin	-1.9K%	↑ 812.77%

	Q2 FY24	Q/Q Change
Revenue	$2.0M	↓ 42.28%
Net Income	$-70.8M	↑ 2.81%
Net Profit Margin	-3.5K%	↓ 1518.35%

	Q3 FY24	Q/Q Change
Revenue	$2.3M	↑ 14.23%
Net Income	$-80.4M	↑ 13.57%
Net Profit Margin	-3.4K%	↑ 20.06%

	FY18	Y/Y Change
Profit	$379.0K	-

	FY19	Y/Y Change
Profit	$-12.2M	↓ 3324.27%

	FY20	Y/Y Change
Profit	$6.8M	↓ 155.54%

	FY21	Y/Y Change
Profit	$9.3M	↑ 37.41%

	FY22	Y/Y Change
Profit	$9.2M	↓ 1.09%

	FY23	Y/Y Change
Profit	$7.5M	↓ 19.13%

	Q2 FY23	Q/Q Change
Profit	$1.1M	↓ 8.58%

	Q3 FY23	Q/Q Change
Profit	$1.5M	↑ 43.89%

	Q4 FY23	Q/Q Change
Profit	$1.6M	↑ 3.95%

	Q1 FY24	Q/Q Change
Profit	$2.9M	↑ 83.9%

	Q2 FY24	Q/Q Change
Profit	$1.4M	↓ 53.2%

	Q3 FY24	Q/Q Change
Profit	$2.3M	↑ 72.02%

	FY18	Y/Y Change
Operating Cash Flow	$-9.7M	-
Investing Cash Flow	$-49.0K	-
Financing Cash Flow	$5.1M	↓ 94.16%

	FY19	Y/Y Change
Operating Cash Flow	$2.5M	↓ 125.79%
Investing Cash Flow	$-235.0K	↑ 379.59%
Financing Cash Flow	$89.2M	↑ 1634.7%

	FY20	Y/Y Change
Operating Cash Flow	$-37.1M	↓ 1590.64%
Investing Cash Flow	$-7.8M	↑ 3212.77%
Financing Cash Flow	$272.0M	↑ 204.86%

	FY21	Y/Y Change
Operating Cash Flow	$-94.8M	↑ 155.44%
Investing Cash Flow	$-82.5M	↑ 959.95%
Financing Cash Flow	$176.3M	↓ 35.19%

	FY22	Y/Y Change
Operating Cash Flow	$-136.3M	↑ 43.72%
Investing Cash Flow	$-190.0M	↑ 130.2%
Financing Cash Flow	$346.2M	↑ 96.34%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$-49.8M	↑ 1.72%
Investing Cash Flow	$46.0M	↑ 0.0%
Financing Cash Flow	$39.0M	↑ 69.73%

Avidity Biosciences Technicals Summary

Sell

Neutral

Buy

Avidity Biosciences is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Avidity Biosciences Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Avidity Biosciences Inc	-29.89%	-18.77%	237.67%	25.66%	41.19%
Regeneron Pharmaceuticals, Inc.	-4.59%	-33.24%	-15.82%	12.66%	90.77%
Biontech Se	-6.0%	34.52%	8.38%	-55.46%	241.9%
Alnylam Pharmaceuticals, Inc.	-3.47%	0.88%	26.71%	50.37%	105.71%
Vertex Pharmaceuticals Incorporated	-12.22%	-14.47%	-0.59%	82.27%	84.0%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Avidity Biosciences Inc	NA	NA	0.0	-2.86	-0.28	-0.18	NA	12.64
Regeneron Pharmaceuticals, Inc.	17.36	17.36	1.04	45.07	0.17	0.07	NA	272.04
Biontech Se	160.8	NA	0.04	-3.11	-0.02	-0.01	NA	79.73
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	-0.19	-15.01	-0.03	NA	0.25
Vertex Pharmaceuticals Incorporated	32.84	NA	1.04	0.54	-0.03	0.12	NA	60.65

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Avidity Biosciences Inc	Buy	$3.8B	41.19%	NA	0.0%
Regeneron Pharmaceuticals, Inc.	Buy	$77.1B	90.77%	17.36	33.61%
Biontech Se	Buy	$27.1B	241.9%	160.8	-15.36%
Alnylam Pharmaceuticals, Inc.	Buy	$31.7B	105.71%	NA	-15.86%
Vertex Pharmaceuticals Incorporated	Buy	$102.3B	84.0%	32.84	-4.51%

Avidity Biosciences Dividend announcements

Avidity Biosciences Earnings
Avidity Biosciences’s price-to-earnings ratio stands at None
Read More

About Avidity Biosciences

avidity biosciences is pioneering a new class of precision medicines – antibody-sirna conjugates (asc™) – to deliver nucleic acid therapeutics against genetic drivers of disease. our ascs have drug-like properties similar to antibodies and antibody-drug conjugates. importantly, their unique sirna-based “payloads” permit selective targeting of disease-associated mrnas against virtually any target of interest. our leadership includes seasoned scientists and executives with deep expertise in the fields of antibody conjugation, chemistry, formulations, oligonucleotide therapeutics, drug delivery and cancer biology. our employees are high energy, creative people who are passionate about solving hard problems and bringing new drugs to patients. we strive to work with partners to discover best-in-class molecules with the goal of long-term, joint value creation. we have also attracted support from top-tier investors including f-prime capital, ecor1 capital, brace pharma and other sophisticated

Organization	Avidity Biosciences
Employees	253
CEO	Dr. Troy Edward Wilson J.D., Ph.D.
Industry	Health Technology

Management People of Avidity Biosciences

Name	Title
Dr. Troy Edward Wilson J.D., Ph.D.	Co-Founder & Independent Chairman
Ms. Sarah Boyce	President, CEO & Director
Mr. Michael F. MacLean CPA	Chief Financial & Chief Business Officer
Dr. W. Michael F. Flanagan Ph.D.	Chief Scientific & Technical Officer
Ms. Teresa McCarthy	Chief Human Resources Officer
Dr. Arthur A. Levin Ph.D.	Distinguished Scientist, Strategic Leader & Director
Mr. Eric B. Mosbrooker	Chief Strategy Officer
Prof. Mark E. Davis Ph.D.	Scientific Founder, Member of Scientific Advisory Board and Member of Board of Managers
Dr. Frank P. McCormick Ph.D.	Scientific Founder & Member of Scientific Advisory Board
Mr. John B. Moriarty Jr., ESQ., J.D.	Chief Legal Officer & Corporate Secretary

Important FAQs about investing in Avidity Biosciences from India :

What is Avidity Biosciences share price today?

Avidity Biosciences share price today stands at $31.64, Open: $31.32 ; Previous Close: $31.82 ; High: $32.11 ; Low: $30.96 ; 52 Week High: $56.00 ; 52 Week Low: $8.86. The stock opens at $31.32, after a previous close of $31.82. The stock reached a daily high of $32.11 and a low of $30.96, with a 52-week high of $56.00 and a 52-week low of $8.86.

Can Indians buy Avidity Biosciences shares?

Yes, Indians can invest in the Avidity Biosciences (RNA) from India.

With INDmoney, you can buy Avidity Biosciences at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Avidity Biosciences at zero transaction cost.

How can I buy Avidity Biosciences shares from India?

It is very easy to buy Avidity Biosciences from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Avidity Biosciences be purchased?

Yes, you can buy fractional shares of Avidity Biosciences with INDmoney app.

What are the documents required to start investing in Avidity Biosciences stocks?

To start investing in Avidity Biosciences, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.